Samsung Biologics
207940.KS
#451
Rank
โ‚ฌ45.66 B
Marketcap
986,55ย โ‚ฌ
Share price
-3.18%
Change (1 day)
39.28%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2025 (TTM): 16,25ย โ‚ฌ

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is 15,81ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 8,80ย โ‚ฌ an increase over its 2023 EPS that were of 7,90ย โ‚ฌ.

EPS history for Samsung Biologics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)16,25ย โ‚ฌ84.74%
20248,80ย โ‚ฌ11.34%
20237,90ย โ‚ฌ2.67%
20227,70ย โ‚ฌ83.43%
20214,20ย โ‚ฌ49.14%
20202,81ย โ‚ฌ26.39%
20192,23ย โ‚ฌ-12.58%
20182,55ย โ‚ฌ-320.64%
2017-1,15ย โ‚ฌ-46.78%
2016-2,17ย โ‚ฌ-105.09%
201542,63ย โ‚ฌ-1089.67%
2014-4,31ย โ‚ฌ